Lessons from Africa: developing a global human rights framework for tuberculosis control and prevention

BMC International Health and Human Rights

Yanis Ben Amor²  Golda Calonge¹  Mehdi Ben Youssef²  Tracy Slagle² 

[1] The School of Social Work, Columbia University, New York, NY, USA;The Earth Institute, Columbia University, New York, NY, USA

关键词: Human rights;    Framework convention;    Drug-resistant tuberculosis;    Tuberculosis;   

Others  :  1113310
DOI  :  10.1186/s12914-014-0034-7

 received in 2014-02-26, accepted in 2014-11-17,  发布年份 2014

【 摘 要 】

Background

Tuberculosis is a highly contagious disease, and there has been a rise in recent years of drug-resistant cases no longer responding to standard treatment.

In order to address this threat and contain possible transmission of drug-resistant cases, some countries have taken strong action, including the compulsory detention of non-adherent drug-resistant patients. These measures have been strongly criticized by human rights advocates, and they raise the question of how to legally protect both citizens and the community.

Discussion

Following discussions with National Tuberculosis Programs in Africa (the continent with the highest incidence rates of tuberculosis worldwide), we show that of all the countries surveyed, all but one (Swaziland) had either no specific policy addressing tuberculosis, or only general policies regarding public health applicable to tuberculosis. Six countries also reported having policies that address non-adherence to treatment with containment (isolation in health facilities or incarceration), but laws are not adequately enforced. If the international community wants to effectively respond to the threat of tuberculosis transmission, there is a need to go beyond national tuberculosis policies and to implement an international framework for tuberculosis control, inspired by the Framework Convention on Tobacco Control, a key model for future public health treaties that address global burdens of disease. The framework, for which we clarify the conditions and procedures in this piece, would define the rights and responsibilities of the different stakeholders involved: patients, doctors, pharmaceutical firms and public authorities. To facilitate the governance of the national obligations under the Convention, a coordinating body should be set up, under the leadership of the World Health Organization and the Stop TB Partnership.

Summary

Successfully implementing policies for tuberculosis that simultaneously address patients’ rights and communities’ wellbeing will have positive implications for those affected by the disease and serve as a basis for other global health conventions to truly ensure the global right to health.

【 授权许可】

   
2014 Slagle et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Global Tuberculosis Control. World Health Organization, Geneva; 2013.
• [2][http://www.who.int/mediacentre/factsheets/fs104/en/] webcite Tuberculosis. Fact sheet # 104. []
• [3]Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. WHO Global Report. World Health Organization, Geneva; 2010.
• [4]Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, et al.: Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 2013, 13(6):529-539.
• [5][http:/ / www.hst.org.za/ news/ samrc-position-statement-detenction -xdr-tb-patients] webcite SAMRC: Detention of Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB). Edited by Council SAMR; 2007. []
• [6]Anyangu-Amu S: Kenya: TB Patients Held in Prison. In Inter Press Service News Agency, Nairobi; 2010.
• [7][http:/ / www.latimes.com/ local/ lanow/ la-me-ln-man-tuberculosis-arrested- 20140729-story.html] webcite Los Angeles Times: Man with tuberculosis who officials say resisted treatment is arrested. 2014. []
• [8][http:/ / www.opensocietyfoundations.org/ voices/ timely-treatment-for-drug-resistant -tb-in-kenya] webcite Howe E: Timely treatment for drug-resistant TB in Kenya. In Open Society Foundations Voices. 2012. []
• [9]Tuberculosis Control Laws and Policies: A Handbook for Public Health and Legal Practitioners. Johns Hopkins and Georgetown Universities, Washington DC; 2009.
• [10]Guidance on Ethics of Tuberculosis Prevention, Care and Control. WHO, Geneva; 2010.
• [11]Tuberculosis, Ethics and Human Rights. World Health Organization, Copenhagen; 2013.
• [12]Townsend B, Martin E, Löfgren H, de Leeuw E: Global Health Governance: Framework Convention on Tobacco Control (FCTC), the Doha Declaration, and Democratisation. Adm Sci 2012, 2:186-202.
• [13]WHO Framework Convention on Tobacco Control. Organization WH, Geneva; 2003.
• [14]Oldring L, Jerbi S: Advancing a Human Rights Approach on the Global Health Agenda. In Realizing the Right to Health. Edited by Zurich Uo. Zurich, Rüffer & Rub; 2009.
• [15][http://www.un.org/en/documents/udhr/] webcite UN: The Universal Declaration of Human Rights. Edited by Nations U; 1948. []
• [16][http://www.un-documents.net/a3r217.htm] webcite UN: International Covenant on Economic, Social and Cultural Rights. In International Bill of Human Rights. 1966. []
• [17]Kuszler P: Global Health and the Human Rights Imperative. Asian J WTO Int Health Law Policy 2007, 2(1):99-124.
• [18][http://www.ohchr.org/Documents/ProfessionalInterest/ccpr.pdf] webcite UN: International Covenant on Civil and Political Rights; 1966. []
• [19][http://www.refworld.org/docid/4538838d0.html] webcite Committee on Economic, Social and Cultural Rights, General Comment 14. 2000. []
• [20][http://www.ohchr.org/en/professionalinterest/pages/crc.aspx] webcite UN: Convention on the Rights of the Child. Edited by Nations U; 1989. []
• [21]African Charter on Human and People’s Rights. 2005.
• [22][http://www.constitutionalcourt.org.za/site/theconstitution/thetext.htm] webcite Constitution of the Republic of South Africa Act. []
• [23][http://www.refworld.org/docid/4672bc122.html] webcite UN: Siracusa Principles on the Limitation and Derogation Provisions in the International Covenant on Civil and Political Rights. 1984. []
• [24]Boggio A, Zignol M, Jaramillo E, Nunn P, Pinet G, Raviglione M: Limitations on human rights: are they justifiable to reduce the burden of TB in the era of MDR- and XDR-TB? Health Hum Rights 2008, 10(2):121-126.
• [25]Sidibe M, Buse K: A framework convention on global health: a catalyst for justice. Bull World Health Organ 2012, 90(12):870-870A.
• [26][http://www.jalihealth.org/documents/Framework.pdf] webcite Campaign for a Framework Convention on Global Health. [ ]
• [27]WHO Policy Update: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children. World Health Organization, Geneva; 2014.
• [28]Lienhardt C, Glaziou P, Uplekar M, Lonnroth K, Getahun H, Raviglione M: Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol 2012, 10(6):407-416.
• [29]Hearn J: The ‘uses and abuses’ of civil society in Africa. Rev Afr Polit Econ 2001, 87:43-53.
• [30]Gostin LO, Friedman EA, Buse K, Waris A, Mulumba M, Joel M, Dare L, Dhai A, Sridhar D: Towards a framework convention on global health. Bull World Health Organ 2013, 91(10):790-793.
• [31]Styblo K: The epidemiological situation of tuberculosis and the impact of control measures. Prax Klin Pneumol 1983, 37(9):346-351.
• [32][http://www.who.int/fctc/signatories_parties/en/index.html] webcite Parties to the WHO Framework Convention on Tobacco Control. [ ]
• [33][http:/ / www.africa.undp.org/ content/ dam/ rba/ docs/ Reports/ RBA-common-position.pdf] webcite African Union: Common African Position on the Post-2015 Development Agenda. In African Union: 2014; Addis Ababa; 2014.
• [34]Coker R, Martin R: Introduction: the importance of law for public health policy and practice. Public Health 2006, 120(Suppl):2-7.
• [35]Ruger JP: Control of Extensively Drug-Resistant Tuberculosis (XDR-TB): A Root Cause Analysis. Glob Health Gov 2010, 3(2):1-20.
• [36][http:/ / www.mhealthknowledge.org/ sites/ default/ files/ 5_mHealth_5Year_Report.pdf] webcite Five years of mobilizing for health impact. Washington DC: mHealth Alliance; 2013. []
• [37]Denkinger CM, Grenier J, Stratis AK, Akkihal A, Pant-Pai N, Pai M: Mobile health to improve tuberculosis care and control: a call worth making. Int J Tuberc Lung Dis 2013, 17(6):719-727.
• [38][http://www.opasha.org/our-work/ecompliance-innovation-and-health/] webcite Operation ASHA: Technology: the eCompliance Project. []
• [39]Farmer P: The consumption of the poor. Tuberculosis in the 21st century. Ethnography 2000, 1(2):183-216.
• [40]Denholm JT, Amon JJ, O’Brien R, Narain A, Kim SJ, El Sony A, Edginton ME: Attitudes towards involuntary incarceration for tuberculosis: a survey of Union members. Int J Tuberc Lung Dis 2014, 18(2):155-159.
• [41]Todrys KW, Amon JJ: Criminal justice reform as HIV and TB prevention in African prisons. PLoS Med 2012, 9(5):e1001215.
• [42]Bantubani N, Kabera G, Connolly C, Rustomjee R, Reddy T, Cohen T, Pym AS: High rates of potentially infectious tuberculosis and multidrug-resistant tuberculosis (MDR-TB) among hospital inpatients in KwaZulu Natal, South Africa indicate risk of nosocomial transmission. PLoS One 2014, 9(3):e90868.
• [43]Gandhi NR, Weissman D, Moodley P, Ramathal M, Elson I, Kreiswirth BN, Mathema B, Shashkina E, Rothenberg R, Moll AP, Friedland G, Sturm AW, Shah NS: Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa. J Infect Dis 2013, 207(1):9-17.
• [44]Harris TG, Sullivan Meissner J, Proops D: Delay in diagnosis leading to nosocomial transmission of tuberculosis at a New York City health care facility. Am J Infect Control 2013, 41(2):155-160.
• [45]Gasner MR, Maw KL, Feldman GE, Fujiwara PI, Frieden TR: The use of legal action in New York City to ensure treatment of tuberculosis. N Engl J Med 1999, 340(5):359-366.
• [46]WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization, Geneva; 2014.
• [47]Singh H, Kaur K, Girish P: Multidrug-resistant Tuberculosis; a Pharmacological View Based on Revised National Tuberculosis Control Programme DOTS-Plus Guidelines. J Pharm 2012, 2(4):62-68.
• [48]Laserson KF, Kenyon AS, Kenyon TA, Layloff T, Binkin NJ: Substandard tuberculosis drugs on the global market and their simple detection. Int J Tuberc Lung Dis 2001, 5(5):448-454.
• [49]WHO Expert Committee on Specifications for Pharmaceutical Preparations: How Does it Work?. World Health Organization, Geneva; 2014.
• [50]The use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis. World Health Organization, Geneva; 2013.
• [51][http://www.who.int/tb/WHO_Info_note_Delamanid.pdf?ua=1] webcite Information note on the use of a new agent, delamanid, for the treatment of multidrug-resistant tuberculosis. [ ]
• [52]Ruggie J: Guiding Principles on Business and Human Rights: Implementing the United Nations “Protect, Respect and Remedy” Framework. UN, New York; 2011.
• [53][http:/ / www.irinnews.org/ report/ 90481/ kenya-activists-appeal-for-release- of-tb-prisoners] webcite Kenya: Activists appeal for release of TB prisoners. In Integrated Regional Information Network (IRIN) Africa. Nairobi; 2010.